MinireviewMechanisms of genetic susceptibility to type I diabetes: beyond HLA
Introduction
Type I diabetes (T1D) is characterized by the autoimmune destruction of β-cells in the pancreas, leading to complete insulin deficiency. There is a large body of evidence suggesting that an individual’s predisposition to developing the chronic disorder is determined largely by one’s genetic makeup. The Human Leukocyte Antigen (HLA) region is the major locus, conferring up to 40–50% of the susceptibility and has been known for over two decades. Of the large number of loci found to be linked by genome-wide scans, only two have been confirmed by the transmission disequilibrium test (TDT) and narrowed down to a single gene. These are the insulin-linked variable number of tandem repeats (INS-VNTR) region and the Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) gene (corresponding, respectively, to the IDDM2 locus and to what had been previously reported as IDDM7, IDDM12, and IDDM13). Together, these two genes confer an inheritable disease risk no larger than 15%. Establishing a causal relationship between common DNA polymorphisms and disease-predisposing functional effect remains a challenge. This review will focus on what is currently known about how DNA variation at the two T1D-associated genes outside the HLA affect human biology to modulate T1D risk.
Section snippets
The INS-VNTR and type I diabetes
Evidence for the involvement of the region near the Insulin gene on Chr11p15 with T1D has long been present [1]. The association of this region with T1D can be attributed with a large degree of probability to the variable number of tandem repeats (VNTR) located in the 5′ upstream region of the insulin gene [2], [3]. The 4.1 kb region encompassing the insulin gene and its flanking regions also contains several other polymorphisms in linkage disequilibrium (LD); all of which are located outside
INS-VNTR and function
The INS-VNTR was postulated early on to exert its effect through transcriptional regulation (in cis) since it does not encode for protein and is directly upstream of the insulin gene promoter (Fig. 1). Due to the location of the paternally expressed [12] Insulin-like Growth factor 2 (IGF2) gene just downstream of the insulin gene, a possible regulatory effect of the VNTR on IGF2 was an alternative possibility.
Initially, insulin gene expression as well as IGF2 gene expression were studied in
Insulin VNTR and thymic insulin expression
A more attractive mechanism for the VNTR effect was identified when ours and other groups looked at insulin expression in the thymus and correlated expression with INS-VNTR. The thymus plays a critical role in determining central tolerance by deleting autoreactive T-cell receptor rearrangements. Of the many putative autoantigens involved in the diabetes disease process, insulin has the highest specificity for the β-cells of the pancreas. In the NOD mouse the many T-cell clones isolated from
Silencing alleles
Although in most thymi examined by our group [24] and by Pugliese et al. [23], insulin expression was expressed by both alleles (in class I/III heterozygotes), 5 thymi out of 22 heterozygous individuals expressed only one allele [23], [24]. All silenced alleles were expressed in cis to a class III VNTR allele. By using a PCR-based restriction fingerprinting analysis that allowed us to distinguish between individual alleles within class III, we were able to demonstrate that those rare alleles
CTLA-4
The 2q31–35 interval in humans, syntenic with the NOD mouse type I diabetes locus Idd5 on chromosome 1, contains at least three type I Diabetes loci (IDDM7, IDDM12, and IDDM13) [33], [34], [35]. Within this 23cM interval, the 2q33 region (previously designated IDDM12,) is linked and associated to autoimmune disease. This region encompasses several potential candidate genes namely, CD28, CTLA-4, and ICOS (Fig. 2) all of which are important players in immune regulation and function and could be
CTLA-4s role in immunity and autoimmunity
CTLA-4s function as a negative regulator of T-cell function makes its association with type I diabetes highly plausible. There are two known isoforms of CTLA-4 in humans: the full-length CTLA-4 is a transmembrane glycoprotein expressed transiently on the surface of activated CD4 and CD8 T-cell populations, although it has also been detected on B-cells and is the main isoform found in adult thymocytes. The soluble CTLA-4 isoform is generated by alternative splicing of the transmembrane domain
The signal peptide polymorphism, an A49G SNP (threonine to alanine substitution) mediates differential expression of cell-surface CTLA-4
The G49 allele of the signal peptide has been consistently overtransmitted from heterozygous parents to affected offspring by the transmission disequilibrium test (TDT) in multiple ethnic groups [34], [52].
Functional evidence in support of this association was initially reported in two studies which showed increased proliferation of T-cells in individuals homozygous for the predisposing G49 allele at the signal peptide coding SNP [68], [69]. In addition, they also showed that this allele
The CTLA-4 promoter
In a case-control study by Ligers et al., CTLA-4 cell-surface levels were quantified by flow cytometry in multiple sclerosis patients vs. matched-controls. When the data were analyzed by promoter and signal peptide (C-318T;A49G) haplotype, significantly higher surface expression in both patients and controls for the T/C;A/A haplotype was found and not for any other haplotype [71]. They also compared lymphocyte expression levels from 44 heterozygous individuals at the promoter (T/C) vs. 186
The CTLA-4 3′UTR
Another obvious candidate for functional effect is the (AT)n repeat at the 3′UTR, a region known to be involved in RNA stability. Regulation of mRNA decay is an important mechanism by which the level of gene expression is controlled. AU-rich elements (AREs) commonly associated with mRNA degradation process, particularly the AUUUA pentamer and the nonamer UUAUUUA(U/A)(U/A), are not present in the CTLA-4 3′UTR. Since these are not always required for a functional ARE, as is the case of the zif278
The alternatively spliced soluble CTLA-4
There has been much excitement recently over a study in which a newly identified SNP, A6230G, in the 3′ flanking region of CTLA-4 was found to be highly associated with Graves’ disease [55]. In type I diabetes the predominance of this SNP was weaker. In three individuals heterozygous for the A49G SNP the authors report higher soluble CTLA-4 mRNA from the disease protective haplotype (A49;A6230) than from the predisposing haplotype (G40;G6230) in unstimulated CD4 T-cells [55]. The observation
Conclusion
This short overview of the functional evaluation of two type I diabetes susceptibility loci known outside the HLA locus (out of a yet unknown number) illustrates the complexity of genetic predisposition to type I diabetes and its functional underpinnings. Much work remains to be done for the discovery the remaining loci and the elucidation of the mechanism by which they alter biology to predispose to disease. It is hoped that such knowledge will permit the rational development of preventive
References (81)
- et al.
Analysis of a 1963-bp polymorphic region flanking the human insulin gene
Gene
(1984) - et al.
IDDM2-VNTR-encoded susceptibility to type 1 diabetes: dominant protection and parental transmission of alleles of the insulin gene-linked minisatellite locus
J. Autoimmun.
(1996) - et al.
Imprinted and genotype-specific expression of genes at the IDDM2 locus in pancreas and leucocytes
J. Autoimmun.
(1996) - et al.
T cell tolerance by clonal elimination in the thymus
Cell
(1987) Negative selection of lymphocytes
Cell
(1994)- et al.
Evidence for a differential avidity model of T cell selection in the thymus
Cell
(1994) - et al.
CTLA-4 gene polymorphisms in Tunisian patients with Graves’ disease
Clin. Immunol.
(2001) - et al.
The CTLA-4 gene is associated with multiple sclerosis
J. Neuroimmunol.
(1999) - et al.
CTLA-4 gene polymorphism may modulate disease in Japanese multiple sclerosis patients
J. Neurol. Sci.
(1999) - et al.
Genetic association of Ctla-4 to myasthenia gravis with thymoma
J. Neuroimmunol.
(1998)
Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequence
J. Neuroimmunol.
A native soluble form of CTLA-4
Cell. Immunol.
Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4
Immunity
Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells
Immunity
CTLA-4 downregulates epitope spreading and mediates remission in relapsing experimental autoimmune encephalomyelitis
J. Neuroimmunol.
Complete sequence determination of the mouse and human CTLA4 gene loci: cross-species DNA sequence similarity beyond exon borders
Genomics
Assembly and annotation of human chromosome 2q33 sequence containing the CD28, CTLA4, and ICOS gene cluster: analysis by computational, comparative, and microarray approaches
Genomics
A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele
J. Biol. Chem.
AU-rich elements: characterization and importance in mRNA degradation
Trends Biochem. Sci.
A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus
Diabetes
Insulin-IGF2 region on chromosome 11p encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility
Nature
Insulin gene region-encoded susceptibility to type 1 diabetes is not restricted to HLA-DR4-positive individuals
Nat. Genet.
Localization of a type I diabetes susceptibility locus to the variable tandem repeat region flanking the insulin gene
Diabetes
Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus
Nat. Genet.
Insulin gene region-encoded susceptibility to IDDM maps upstream of the insulin gene
Diabetes
Diabetes susceptibility at IDDM2 cannot be positively mapped to the VNTR locus of the insulin gene
Diabetologia
Genetic analysis of the hypervariable region flanking the human insulin gene
Am. J. Hum. Genet.
Susceptibility to insulin dependent diabetes mellitus maps to a 4.1 kb segment of DNA spanning the insulin gene and associated VNTR
Nat. Genet.
Parental genomic imprinting of the human IGF2 gene
Nat. Genet.
Divergence between genetic determinants of IGF2 transcription levels in leukocytes and of IDDM2-encoded susceptibility to type 1 diabetes
J. Clin. Endocrinol. Metab.
The minisatellite in the diabetes susceptibility locus IDDM2 regulates insulin transcription
Nat. Genet.
Regulation of insulin gene expression by the IDDM associated, insulin locus haplotype
Hum. Mol. Genet.
The search for IDDM susceptibility genes: the next generation
Diabetes
Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice
Eur. J. Immunol.
Diabetogenic T-cell clones
Diabetes
Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library
Nat. Med.
Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice
Diabetes
T-cell tolerance toward a transgenic beta-cell antigen and transcription of endogenous pancreatic genes in thymus
Proc. Natl. Acad. Sci. USA
The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes
Nat. Genet.
Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus
Nat. Genet.
Cited by (70)
Molecular aspects and biochemical regulation of diabetes mellitus
2019, Molecular Nutrition CarbohydratesMachine Learning and Data Mining Methods in Diabetes Research
2017, Computational and Structural Biotechnology JournalDo personality traits moderate the manifestation of type 2 diabetes genetic risk?
2015, Journal of Psychosomatic ResearchDiagnosis and classification of autoimmune diabetes mellitus
2014, Autoimmunity ReviewsCitation Excerpt :The development of immune-based diabetes (henceforth referred to here as T1A) involves a degree of susceptibility. This susceptibility is mostly inherited, predominantly in the HLA genotypes DR and DQ, and to a lesser extent in a host of other genetic loci [29]. Recent genetic mapping studies and gene-phenotype studies shed light on the possible origins of T1A by indicating potential disease-relevant biological pathways [30].